Article

The association between disability progression, relapses, and treatment in early relapse onset MS: an observational, multi-center, longitudinal cohort study

2022-04-27

Abstract excerpt

<title>Abstract</title> <p>The contribution of multiple sclerosis relapses to worsening of disability, and vice-versa, remains unclear. Vitamin D supplementation (VitD) and disease modifying therapies (DMTs) are potential modulators of this association. Understanding how these endo-phenotypes interact may provide insights to disease pathogenesis and treatment practice. Here, we examined independent associations b...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 780220b5-8bce-5771-b835-8a1dfe449292
DOI: 10.21203/rs.3.rs-1547958/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The association between disability progression, relapses, and treatment in early relapse onset MS: an observational, multi-center, longitudinal cohort studyDOI 10.21203/rs.3.rs-1547958/v1Read

Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic Review.Semantic proximity Read

Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry.Semantic proximity Read

Association between multiple sclerosis risk-associated SNPs and relapse and disability--a prospective cohort study.Semantic proximity Read

Specific clinical phenotypes in relapsing multiple sclerosis: The impact of relapses on long-term outcomes.Semantic proximity Read

Multiple sclerosis relapse phenotype is an important, neglected, determinant of disease outcome - YES.Semantic proximity Read

Multiple sclerosis relapse phenotype is an important, neglected determinant of disease-outcome: Commentary.Semantic proximity Read

Multiple sclerosis relapse phenotype is an important, neglected, determinant of disease outcome - NO.Semantic proximity Read

Predicting personalised risk of disability worsening in multiple sclerosis with machine learningSemantic proximity Read

The 2013 clinical course descriptors for multiple sclerosis: A clarification.Semantic proximity Read

Serum 25-Hydroxyvitamin D and Neurological Disability in Multiple Sclerosis: A Cross-Sectional Study from the Mediterranean Epidemiological FrontierSemantic proximity Read

Quantifying MS Progression in the Era of Highly Effective Therapy: Trial Design ImplicationsSemantic proximity Read

Effect of Early Treatment Intensity on Progression Independent of Relapse Activity and Disability Accumulation in Multiple SclerosisSemantic proximity Read